Logo image of SMG

SCOTTS MIRACLE-GRO CO (SMG) Stock Fundamental Analysis

USA - NYSE:SMG - US8101861065 - Common Stock

59.03 USD
+1.21 (+2.09%)
Last: 10/8/2025, 8:14:46 PM
59.03 USD
0 (0%)
After Hours: 10/8/2025, 8:14:46 PM
Fundamental Rating

4

SMG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. SMG has a medium profitability rating, but doesn't score so well on its financial health evaluation. SMG has a decent growth rate and is not valued too expensively. Finally SMG also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SMG was profitable.
In the past year SMG had a positive cash flow from operations.
In multiple years SMG reported negative net income over the last 5 years.
SMG had a positive operating cash flow in 4 of the past 5 years.
SMG Yearly Net Income VS EBIT VS OCF VS FCFSMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.72%, SMG is in line with its industry, outperforming 56.63% of the companies in the same industry.
With an excellent Return On Invested Capital value of 14.61%, SMG belongs to the best of the industry, outperforming 93.98% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SMG is above the industry average of 6.36%.
The last Return On Invested Capital (14.61%) for SMG is above the 3 year average (10.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.72%
ROE N/A
ROIC 14.61%
ROA(3y)-7.51%
ROA(5y)-0.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.63%
ROIC(5y)13.54%
SMG Yearly ROA, ROE, ROICSMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

SMG has a Profit Margin (1.54%) which is comparable to the rest of the industry.
SMG has a Operating Margin of 12.32%. This is in the better half of the industry: SMG outperforms 67.47% of its industry peers.
In the last couple of years the Operating Margin of SMG has declined.
SMG has a Gross Margin (29.77%) which is in line with its industry peers.
SMG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 12.32%
PM (TTM) 1.54%
GM 29.77%
OM growth 3Y-13.17%
OM growth 5Y-5.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.65%
GM growth 5Y-4.15%
SMG Yearly Profit, Operating, Gross MarginsSMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SMG is still creating some value.
The number of shares outstanding for SMG has been increased compared to 1 year ago.
Compared to 5 years ago, SMG has more shares outstanding
Compared to 1 year ago, SMG has a worse debt to assets ratio.
SMG Yearly Shares OutstandingSMG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SMG Yearly Total Debt VS Total AssetsSMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

SMG has an Altman-Z score of 2.60. This is not the best score and indicates that SMG is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.60, SMG is doing good in the industry, outperforming 75.90% of the companies in the same industry.
The Debt to FCF ratio of SMG is 8.95, which is on the high side as it means it would take SMG, 8.95 years of fcf income to pay off all of its debts.
SMG's Debt to FCF ratio of 8.95 is fine compared to the rest of the industry. SMG outperforms 69.88% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.95
Altman-Z 2.6
ROIC/WACC1.67
WACC8.76%
SMG Yearly LT Debt VS Equity VS FCFSMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

SMG has a Current Ratio of 1.61. This is a normal value and indicates that SMG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.61, SMG is doing worse than 67.47% of the companies in the same industry.
SMG has a Quick Ratio of 1.61. This is a bad value and indicates that SMG is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.93, SMG is doing worse than 71.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 0.93
SMG Yearly Current Assets VS Current LiabilitesSMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.33% over the past year.
Measured over the past years, SMG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.83% on average per year.
The Revenue has decreased by -2.05% in the past year.
The Revenue has been growing slightly by 2.40% on average over the past years.
EPS 1Y (TTM)89.33%
EPS 3Y-37.53%
EPS 5Y-12.83%
EPS Q2Q%12.12%
Revenue 1Y (TTM)-2.05%
Revenue growth 3Y-10.32%
Revenue growth 5Y2.4%
Sales Q2Q%-1.18%

3.2 Future

The Earnings Per Share is expected to grow by 24.93% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.46% on average over the next years.
EPS Next Y67.36%
EPS Next 2Y39.83%
EPS Next 3Y32.35%
EPS Next 5Y24.93%
Revenue Next Year-3.72%
Revenue Next 2Y-1.11%
Revenue Next 3Y-0.07%
Revenue Next 5Y0.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SMG Yearly Revenue VS EstimatesSMG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
SMG Yearly EPS VS EstimatesSMG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.52, which indicates a rather expensive current valuation of SMG.
61.45% of the companies in the same industry are more expensive than SMG, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SMG to the average of the S&P500 Index (27.91), we can say SMG is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 13.48, the valuation of SMG can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SMG indicates a somewhat cheap valuation: SMG is cheaper than 63.86% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.30, SMG is valued a bit cheaper.
Industry RankSector Rank
PE 17.52
Fwd PE 13.48
SMG Price Earnings VS Forward Price EarningsSMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SMG is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, SMG is valued cheaply inside the industry as 80.72% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.93
EV/EBITDA 11.08
SMG Per share dataSMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

SMG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SMG's earnings are expected to grow with 32.35% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y39.83%
EPS Next 3Y32.35%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.52%, SMG is a good candidate for dividend investing.
SMG's Dividend Yield is rather good when compared to the industry average which is at 3.61. SMG pays more dividend than 84.34% of the companies in the same industry.
SMG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

The dividend of SMG has a limited annual growth rate of 3.51%.
SMG has paid a dividend for at least 10 years, which is a reliable track record.
SMG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)3.51%
Div Incr Years0
Div Non Decr Years3
SMG Yearly Dividends per shareSMG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

SMG pays out 289.64% of its income as dividend. This is not a sustainable payout ratio.
SMG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP289.64%
EPS Next 2Y39.83%
EPS Next 3Y32.35%
SMG Yearly Income VS Free CF VS DividendSMG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M
SMG Dividend Payout.SMG Dividend Payout, showing the Payout Ratio.SMG Dividend Payout.PayoutRetained Earnings

SCOTTS MIRACLE-GRO CO

NYSE:SMG (10/8/2025, 8:14:46 PM)

After market: 59.03 0 (0%)

59.03

+1.21 (+2.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners78.72%
Inst Owner Change0%
Ins Owners0.51%
Ins Owner Change-0.3%
Market Cap3.41B
Analysts76.92
Price Target75.82 (28.44%)
Short Float %7.87%
Short Ratio4.46
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly Dividend2.66
Dividend Growth(5Y)3.51%
DP289.64%
Div Incr Years0
Div Non Decr Years3
Ex-Date08-22 2025-08-22 (0.66)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.29%
Min EPS beat(2)-0.27%
Max EPS beat(2)12.85%
EPS beat(4)2
Avg EPS beat(4)6.18%
Min EPS beat(4)-16.32%
Max EPS beat(4)28.45%
EPS beat(8)6
Avg EPS beat(8)7.66%
EPS beat(12)8
Avg EPS beat(12)6.19%
EPS beat(16)11
Avg EPS beat(16)4.76%
Revenue beat(2)0
Avg Revenue beat(2)-5.07%
Min Revenue beat(2)-6.02%
Max Revenue beat(2)-4.12%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-6.02%
Max Revenue beat(4)5.18%
Revenue beat(8)4
Avg Revenue beat(8)1.01%
Revenue beat(12)5
Avg Revenue beat(12)-0.37%
Revenue beat(16)6
Avg Revenue beat(16)-0.19%
PT rev (1m)-1.76%
PT rev (3m)3.96%
EPS NQ rev (1m)-0.33%
EPS NQ rev (3m)-9.02%
EPS NY rev (1m)0.42%
EPS NY rev (3m)4.64%
Revenue NQ rev (1m)-0.42%
Revenue NQ rev (3m)1.44%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.95%
Valuation
Industry RankSector Rank
PE 17.52
Fwd PE 13.48
P/S 0.99
P/FCF 13.93
P/OCF 10.8
P/B N/A
P/tB N/A
EV/EBITDA 11.08
EPS(TTM)3.37
EY5.71%
EPS(NY)4.38
Fwd EY7.42%
FCF(TTM)4.24
FCFY7.18%
OCF(TTM)5.47
OCFY9.26%
SpS59.59
BVpS-2.96
TBVpS-14.28
PEG (NY)0.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.72%
ROE N/A
ROCE 18.49%
ROIC 14.61%
ROICexc 14.94%
ROICexgc 21.1%
OM 12.32%
PM (TTM) 1.54%
GM 29.77%
FCFM 7.11%
ROA(3y)-7.51%
ROA(5y)-0.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.63%
ROIC(5y)13.54%
ROICexc(3y)10.91%
ROICexc(5y)13.96%
ROICexgc(3y)15.3%
ROICexgc(5y)22.83%
ROCE(3y)13.46%
ROCE(5y)17.14%
ROICexcg growth 3Y-10.58%
ROICexcg growth 5Y-6.7%
ROICexc growth 3Y-7.68%
ROICexc growth 5Y0%
OM growth 3Y-13.17%
OM growth 5Y-5.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.65%
GM growth 5Y-4.15%
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.95
Debt/EBITDA 4.27
Cap/Depr 92.94%
Cap/Sales 2.07%
Interest Coverage 3.11
Cash Conversion 63.09%
Profit Quality 460.64%
Current Ratio 1.61
Quick Ratio 0.93
Altman-Z 2.6
F-Score8
WACC8.76%
ROIC/WACC1.67
Cap/Depr(3y)104.14%
Cap/Depr(5y)98.52%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.33%
EPS 3Y-37.53%
EPS 5Y-12.83%
EPS Q2Q%12.12%
EPS Next Y67.36%
EPS Next 2Y39.83%
EPS Next 3Y32.35%
EPS Next 5Y24.93%
Revenue 1Y (TTM)-2.05%
Revenue growth 3Y-10.32%
Revenue growth 5Y2.4%
Sales Q2Q%-1.18%
Revenue Next Year-3.72%
Revenue Next 2Y-1.11%
Revenue Next 3Y-0.07%
Revenue Next 5Y0.46%
EBIT growth 1Y23.95%
EBIT growth 3Y-22.13%
EBIT growth 5Y-3.01%
EBIT Next Year58.52%
EBIT Next 3Y23.69%
EBIT Next 5Y17.18%
FCF growth 1Y-46.59%
FCF growth 3Y52.48%
FCF growth 5Y25.91%
OCF growth 1Y-42.21%
OCF growth 3Y34.97%
OCF growth 5Y24.1%